Protalix Biotherapeutics Inc
PLX2.220USD
-0.160-6.72%
收盘 11/06, 16:00（美东）报价延迟15分钟
177.01M总市值
28.21市盈率 TTM
关于 Protalix Biotherapeutics Inc 公司
Protalix BioTherapeutics, Inc. 是一家生物制药公司。该公司专注于通过其专有的植物细胞表达系统 ProCellEx 表达重组治疗蛋白的开发和商业化。此外，该公司正在开发用于治疗严重痛风的聚乙二醇化尿酸酶或 PRX-115、用于治疗 NET 相关疾病的长效 (LA) DNase I 或 PRX-119，以及其他技术和临床前资产。其产品 Elelyso 是一种用于治疗戈谢病患者的酶替代疗法 (ERT)。其 ProCellEx 平台用于制造其已获批和上市的产品以及 PRX-115 和 PRX-119。PRX-115 是一种植物细胞表达的重组聚乙二醇化尿酸酶（尿酸氧化酶），这是一种正在开发的化学修饰酶，可用于治疗严重痛风。 PRX-119 是一种植物细胞表达的聚乙二醇化重组人 DNase I 候选产品。
Protalix Biotherapeutics Inc简介
公司代码PLX
公司名称Protalix Biotherapeutics Inc
上市日期Sep 06, 2010
CEOMr. Dror Bashan
员工数量207
证券类型Ordinary Share
年结日Sep 06
公司地址2 University Plaza
城市HACKENSACK
上市交易所Euronext Paris
国家United States of America
邮编07601
电话12016969345
网址https://protalix.com/
公司代码PLX
上市日期Sep 06, 2010
CEOMr. Dror Bashan
Protalix Biotherapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.28M
--
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
303.00K
+74.14%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
207.30K
--
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
40.00
--
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
40.00
--
Mr. Mike Moyer
Mr. Mike Moyer
Investor Relations
Investor Relations
--
--
Mr. Amos Bar Shalev
Mr. Amos Bar Shalev
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Independent Director
Independent Director
--
--
Dr. Eliot Richard Forster, Ph.D.
Dr. Eliot Richard Forster, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Gilad Mamlok
Mr. Gilad Mamlok
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.28M
--
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
303.00K
+74.14%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
207.30K
--
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
40.00
--
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
40.00
--
Mr. Mike Moyer
Mr. Mike Moyer
Investor Relations
Investor Relations
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 10月23日 周四
更新时间: 10月23日 周四
持股股东
股东类型
持股股东
持股股东
占比
HIR Investments Ltd
5.91%
BlackRock Institutional Trust Company, N.A.
3.77%
Bashan (Dror)
2.86%
Renaissance Technologies LLC
2.03%
Geode Capital Management, L.L.C.
1.04%
其他
84.40%
持股股东
持股股东
占比
HIR Investments Ltd
5.91%
BlackRock Institutional Trust Company, N.A.
3.77%
Bashan (Dror)
2.86%
Renaissance Technologies LLC
2.03%
Geode Capital Management, L.L.C.
1.04%
其他
84.40%
股东类型
持股股东
占比
Investment Advisor
8.56%
Corporation
5.91%
Individual Investor
4.33%
Investment Advisor/Hedge Fund
3.78%
Hedge Fund
2.19%
Research Firm
0.32%
Pension Fund
0.14%
Venture Capital
0.09%
Bank and Trust
0.09%
其他
74.59%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
176
12.12M
15.21%
+1.33M
2025Q2
183
18.79M
23.60%
+3.26M
2025Q1
182
19.45M
25.30%
+4.26M
2024Q4
169
15.65M
21.26%
-1.03M
2024Q3
162
14.11M
19.17%
-5.41M
2024Q2
163
16.36M
22.25%
-4.44M
2024Q1
143
16.45M
23.43%
-4.40M
2023Q4
145
17.20M
24.67%
-3.21M
2023Q3
142
16.45M
24.08%
-6.46M
2023Q2
132
16.38M
24.76%
-4.13M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
HIR Investments Ltd
4.71M
5.91%
--
--
Apr 30, 2025
BlackRock Institutional Trust Company, N.A.
3.00M
3.77%
+2.84M
+1741.73%
Jun 30, 2025
Bashan (Dror)
2.28M
2.86%
--
--
Apr 30, 2025
Renaissance Technologies LLC
1.62M
2.03%
+426.05K
+35.83%
Jun 30, 2025
Geode Capital Management, L.L.C.
826.33K
1.04%
+826.33K
--
Jun 30, 2025
Northern Trust Global Investments Limited
689.88K
0.87%
+6.58K
+0.96%
Jun 30, 2025
Rubin (Eyal)
660.91K
0.83%
+90.91K
+15.95%
Apr 30, 2025
Stratos Wealth Partners, Ltd.
350.00K
0.44%
+3.60K
+1.04%
Jun 30, 2025
Connor, Clark & Lunn Investment Management Ltd.
496.22K
0.62%
+13.34K
+2.76%
Jun 30, 2025
The Vanguard Group, Inc.
484.80K
0.61%
+484.80K
--
Jun 30, 2025
查看更多
持股ETF
更新时间: 21 小时前
更新时间: 21 小时前
机构名称
占比
iShares Micro-Cap ETF
0.03%
ProShares UltraPro Russell2000
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.03%
ProShares UltraPro Russell2000
占比0.01%
Franklin US Small Cap Multifactor Index ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
Global X Russell 2000 ETF
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
